Annual EPS
-$2.78
+$4.50+61.81%
December 31, 2023
Summary
- As of February 28, 2025, VYNE annual earnings per share is -$2.78, with the most recent change of +$4.50 (+61.81%) on December 31, 2023.
- During the last 3 years, VYNE annual EPS has risen by +$139.06 (+98.04%).
- VYNE annual EPS is now at all-time high.
Performance
VYNE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.29
-$0.07-31.82%
September 30, 2024
Summary
- As of February 28, 2025, VYNE quarterly earnings per share is -$0.29, with the most recent change of -$0.07 (-31.82%) on September 30, 2024.
- Over the past year, VYNE quarterly EPS has dropped by -$0.07 (-31.82%).
- VYNE quarterly EPS is now -116.11% below its all-time high of $1.80, reached on December 31, 2020.
Performance
VYNE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.10
+$1.72+61.02%
September 30, 2024
Summary
- As of February 28, 2025, VYNE TTM earnings per share is -$1.10, with the most recent change of +$1.72 (+61.02%) on September 30, 2024.
- Over the past year, VYNE TTM EPS has increased by +$1.72 (+61.02%).
- VYNE TTM EPS is now at all-time high.
Performance
VYNE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
VYNE EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.8% | -31.8% | +61.0% |
| 3 y3 years | +98.0% | +91.3% | +85.1% |
| 5 y5 years | +98.4% | +91.3% | +85.1% |
VYNE EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +89.2% | -119.2% | +92.7% | at high | +95.8% |
| 5 y | 5-year | at high | +98.8% | -116.1% | +99.7% | at high | +99.6% |
| alltime | all time | at high | +98.8% | -116.1% | +99.7% | at high | +99.6% |
VYNE Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.29(+31.8%) | -$1.10(-61.0%) |
| Jun 2024 | - | -$0.22(+46.7%) | -$2.82(-50.4%) |
| Mar 2024 | - | -$0.15(-65.8%) | -$5.69(-21.8%) |
| Dec 2023 | -$2.78(-61.8%) | -$0.44(-78.2%) | -$7.28(-28.4%) |
| Sep 2023 | - | -$2.01(-35.0%) | -$10.17(-8.4%) |
| Jun 2023 | - | -$3.09(+77.6%) | -$11.10(+4.3%) |
| Mar 2023 | - | -$1.74(-47.7%) | -$10.64(+44.0%) |
| Dec 2022 | -$7.28(-71.6%) | -$3.33(+13.3%) | -$7.39(-7.9%) |
| Sep 2022 | - | -$2.94(+11.8%) | -$8.02(-35.6%) |
| Jun 2022 | - | -$2.63(-274.2%) | -$12.46(-26.1%) |
| Mar 2022 | - | $1.51(-138.1%) | -$16.85(-35.0%) |
| Dec 2021 | -$25.64(-81.9%) | -$3.96(-46.3%) | -$25.92(+28.6%) |
| Sep 2021 | - | -$7.38(+5.1%) | -$20.16(-13.8%) |
| Jun 2021 | - | -$7.02(-7.1%) | -$23.40(-77.4%) |
| Mar 2021 | - | -$7.56(-520.0%) | -$103.32(-37.0%) |
| Dec 2020 | -$141.84 | $1.80(-116.9%) | -$163.98(-28.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$10.62(-87.8%) | -$229.86(-14.8%) |
| Jun 2020 | - | -$86.94(+27.4%) | -$269.64(+16.0%) |
| Mar 2020 | - | -$68.22(+6.5%) | -$232.38(+4.4%) |
| Dec 2019 | -$222.48(+30.4%) | -$64.08(+27.1%) | -$222.48(+4.4%) |
| Sep 2019 | - | -$50.40(+1.4%) | -$213.12(+5.0%) |
| Jun 2019 | - | -$49.68(-14.8%) | -$203.04(+13.3%) |
| Mar 2019 | - | -$58.32(+6.6%) | -$179.28(+3.8%) |
| Dec 2018 | -$170.64(+67.9%) | -$54.72(+35.7%) | -$172.80(+14.8%) |
| Sep 2018 | - | -$40.32(+55.6%) | -$150.51(-6.6%) |
| Jun 2018 | - | -$25.92(-50.0%) | -$161.18(-7.2%) |
| Mar 2018 | - | -$51.84(+59.9%) | -$173.65(+11.3%) |
| Dec 2017 | -$101.65(+15.8%) | -$32.43(-36.4%) | -$155.97(+1.5%) |
| Sep 2017 | - | -$50.99(+32.8%) | -$153.72(+49.6%) |
| Jun 2017 | - | -$38.39(+12.4%) | -$102.73(+59.7%) |
| Mar 2017 | - | -$34.16(+13.2%) | -$64.34(+113.2%) |
| Dec 2016 | -$87.78(+205.3%) | -$30.18 | -$30.18 |
| Dec 2015 | -$28.75 | - | - |
FAQ
- What is VYNE Therapeutics annual earnings per share?
- What is the all time high annual EPS for VYNE Therapeutics?
- What is VYNE Therapeutics annual EPS year-on-year change?
- What is VYNE Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly EPS year-on-year change?
- What is VYNE Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for VYNE Therapeutics?
- What is VYNE Therapeutics TTM EPS year-on-year change?
What is VYNE Therapeutics annual earnings per share?
The current annual EPS of VYNE is -$2.78
What is the all time high annual EPS for VYNE Therapeutics?
VYNE Therapeutics all-time high annual earnings per share is -$2.78
What is VYNE Therapeutics annual EPS year-on-year change?
Over the past year, VYNE annual earnings per share has changed by +$4.50 (+61.81%)
What is VYNE Therapeutics quarterly earnings per share?
The current quarterly EPS of VYNE is -$0.29
What is the all time high quarterly EPS for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly earnings per share is $1.80
What is VYNE Therapeutics quarterly EPS year-on-year change?
Over the past year, VYNE quarterly earnings per share has changed by -$0.07 (-31.82%)
What is VYNE Therapeutics TTM earnings per share?
The current TTM EPS of VYNE is -$1.10
What is the all time high TTM EPS for VYNE Therapeutics?
VYNE Therapeutics all-time high TTM earnings per share is -$1.10
What is VYNE Therapeutics TTM EPS year-on-year change?
Over the past year, VYNE TTM earnings per share has changed by +$1.72 (+61.02%)